Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
HET0016 | C12H18N2O | 339068-25-6 | Details |
Albendazole;SKF-62979 | C12H15N3O2S | 54965-21-8 | Details |
Camicinal;GSK962040 | C25H33FN4O | 923565-21-3 | Details |
HCV-IN-29 | C26H32Cl4N6 | 1009119-83-8 | Details |
HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
GSK-J2 | C22H23N5O2 | 1394854-52-4 | Details |
Fiboflapon;AM-803;GSK2190915 | C38H43N3O4S | 936350-00-4 | Details |
Heptasaccharide Glc4Xyl3 | C39H66O33 | 121591-98-8 | Details |
Guanfu base H;Atisinium chloride | C22H34ClNO2 | 4758-99-0 | Details |
Cathepsin Inhibitor 2 | C19H21F6N3O | 1017931-53-1 | Details |
GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
GSK2593074A;GSK'074 | C27H23N5OS | 1337531-06-2 | Details |
GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
Heptamidine dimethanesulfonate;SBi4211 dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
Guaiapate;Mg 5454;Klamar | C18H29NO4 | 852-42-6 | Details |
Guanfu base I;Acorine | C22H29NO5 | 110225-59-7 | Details |
GSK2239633A | C24H25ClN4O5S2 | 1240516-71-5 | Details |
Molibresib besylate;GSK 525762C;I-BET 762 besylate | C28H28ClN5O5S | 1895049-20-3 | Details |
hDHODH-IN-1 | C17H14N2O2 | 1173715-42-8 | Details |
Roxithromycin;Roxl-150;RU-28965 | C41H76N2O15 | 80214-83-1 | Details |
Gum arabic;Arabic gum | N/A | 9000-01-5 | Details |
GSTO1-IN-1 | C10H12Cl2N2O3S | 568544-03-6 | Details |
GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
HCV-IN-7 hydrochloride | C40H49ClN8O6S | 1449756-87-9 | Details |
H-89;Protein kinase inhibitor H-89 | C20H20BrN3O2S | 127243-85-0 | Details |
GSK256066 Trifluoroacetate;GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | C29H27F3N4O7S | 1415560-64-3 | Details |
HA155;CS-963 | C24H19BFNO5S | 1312201-00-5 | Details |
GSK 525768A | C22H22ClN5O2 | 1260530-25-3 | Details |
HCV-IN-3 | C13H11F2NO | 1401839-25-5 | Details |
Helioxanthin 8-1;Helioxanthin analogue 8-1 | C20H12N2O6 | 840529-13-7 | Details |
GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
GSK2850163 | C24H29Cl2N3O | 2121989-91-9 | Details |
Haloperidol (D4');Haloperidol D4' | C21H19ClD4FNO2 | 136765-35-0 | Details |
GW311616 | C19H31N3O4S | 198062-54-3 | Details |
Helvolic acid;Fumigacin | C33H44O8 | 29400-42-8 | Details |
GW 766994;GW 994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
Trimethoprim;NIH 204;BW 56-72;NSC-106568 | C14H18N4O3 | 738-70-5 | Details |
hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
GW274150 | C8H17N3O2S | 210354-22-6 | Details |
GV-196771A | C20H15Cl2N2NaO3 | 166974-23-8 | Details |
Camicinal hydrochloride;GSK962040 hydrochloride | C25H34ClFN4O | 923565-22-4 | Details |
Fiboflapon sodium;GSK2190915 sodium salt;AM-803 sodium | C38H44N3NaO4S | 1196070-26-4 | Details |
GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
GSK-843;GSK'843 | C19H15N5S2 | 1601496-05-2 | Details |
Menbutone;Genabilin;Genabilic acid;Naftobil | C15H14O4 | 3562-99-0 | Details |
Guanoxabenz;Hydroxyguanabenz | C8H8Cl2N4O | 24047-25-4 | Details |
H-Ser-His-OH | C9H14N4O4 | 67726-09-4 | Details |
HCV-IN-30 | C36H44N6O4 | 1007882-23-6 | Details |
GV-58 | C18H26N6OS | 1402821-41-3 | Details |
GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
Rifaximin | C43H51N3O11 | 80621-81-4 | Details |
Helioxanthin derivative 5-4-2;Helioxanthin 5-4-2 | C20H13NO5 | 203935-39-1 | Details |
GSK656 | C10H14BCl2NO4 | 2131798-13-3 | Details |
H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
GSK3368715;EPZ019997 | C20H38N4O2 | 1629013-22-4 | Details |
GSK3368715 dihydrochloride;EPZ019997 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
GSK-3β inhibitor 2 | C14H14N4O3S | 1702428-31-6 | Details |
GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
hDHODH-IN-2 | C19H16N2O2 | 183946-00-1 | Details |
GSK-5498A | C18H11F6N3O | 1253186-49-0 | Details |
GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
Epelsiban;GSK 557296 | C30H38N4O4 | 872599-83-2 | Details |
GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
GSK2945 | C20H18Cl2N2O2S | 1438071-12-5 | Details |
GSK3532795;BMS-955176 | C42H62N2O4S | 1392312-45-6 | Details |
GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
HDAC-IN-4 | C20H21N3O2 | 1252003-13-6 | Details |
HDACs/mTOR Inhibitor 1 | C28H38N8O5 | 2271413-06-8 | Details |
DPP-IV-IN-2;H-Lys(4-nitro-Z)-pyrrolidide | C18H26N4O5 | 136259-18-2 | Details |
Haloperidol D4 | C21H19ClD4FNO2 | 1189986-59-1 | Details |
Guanosine-5'-triphosphate disodium salt;5'-GTP disodium salt | C10H17N5NaO14P3 | 56001-37-7 | Details |
GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
Haemanthamine | C17H19NO4 | 466-75-1 | Details |
H100 | C18H16N2O6S | 643727-55-3 | Details |
hDDAH-1-IN-1 TFA | C10H21F3N4O3 | 1229238-70-3 | Details |
Fenofibrate;Lipantil;Lipanthyl;Procetofen | C20H21ClO4 | 49562-28-9 | Details |
Heptamidine;SBi4211 | C21H28N4O2 | 94345-47-8 | Details |
GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
GZD856 | C29H27F3N6O | 1257628-64-0 | Details |
GW311616 hydrochloride;GW311616A | C19H32ClN3O4S | 197890-44-1 | Details |
Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
Mebendazole;Vermox;Mebenvet;Telmin;Pantelmin | C16H13N3O3 | 31431-39-7 | Details |
HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
Guancydine;Guancidine | C7H14N4 | 1113-10-6 | Details |
Gusperimus trihydrochloride;BMS181173;NKT-01;Spanidin | C17H37N7O3.3ClH | 85468-01-5 | Details |
GSK2983559 free acid | C21H23N4O7PS2 | 1579965-12-0 | Details |
GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
GSK840;GSK'840 | C21H23N3O3 | 2361146-30-5 | Details |
HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
Product Total: Product Page: | ||||
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 |